
## **Trustees’ Annual Report for the period** 

## **From 05/05/2022 Period start date To       30/06/2022          Period end date** 

## **Charity name: Action on Womb Cancer** 

## **Charity registration number: 1198831** 

## **Objectives and Activities** 

||SORP<br>reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|The objects of the CIO are to relieve<br>sickness and to preserve and protect the<br>health of patients suffering from womb<br>cancer for the public benefit,|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17<br>and 1.19|1. Developing a local and national support<br>infrastructure for womb cancer sufferers at<br>the time of diagnosis, during and after their<br>treatment, and in the event of any<br>recurrence;<br>2. Increasing awareness of womb cancer,<br>both in the general population and in<br>primary / secondary healthcare;<br>3. Providing factually correct information<br>about womb cancer and its prognosis; and<br>4. Funding research into the causes,<br>pathophysiology, prognosis, treatment and<br>patient understanding of womb cancer.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|Yes, the Trustees have received this.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

||<br>SORP<br>reference||
|---|---|---|
|Policy on grant making|Para 1.38|None currently in place agreed by<br>Trustees.|
|Policy on social investment<br>including program related<br>investment|Para 1.38|None currently in place agreed by<br>Trustees.|





|Contribution made by<br>volunteers|Para 1.38|None currently in place agreed by<br>Trustees.|
|---|---|---|
|Other||N/A|



## **Achievements and Performance** 

||SORP<br>reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|The charity during this period has made<br>available information material online to the<br>community through its website. This<br>endeavour was bolstered by social media.<br>These efforts eventually culminated in the<br>updating of the website in the current<br>financial year and the delivery of clinician<br>led patient information evenings.|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

|<br>Achievements against<br>objectives set|<br>Para 1.41|<br>N/A|
|---|---|---|
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41|N/A|
|Investment performance<br>against objectives|Para 1.41|N/A|
||||





Other
NIA

## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|Currently over £12,000 reserves to be<br>spent on improving information availability<br>and to advertise the charity to potential<br>beneficiaries through clinical outreach<br>services.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|Reserves currently meeting the provision of<br>information for patients but is insufficient in<br>supporting meaningful research<br>programmes. As a result, the reserves are<br>being accumulated until this becomes<br>possible.|
|Amount of reserves held|Para 1.22|£12,967|
|Reasons for holding zero<br>reserves|Para 1.22|N/A|
|Details of fund materially in<br>deficit|Para 1.24|N/A|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|N/A|



## **Additional information (optional)** 

## You may choose to include further statements where relevant about: 

|<br>The charity’s principal<br>sources of funds (including<br>any fundraising)|<br>Para 1.47|<br>Donations principally|
|---|---|---|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46|N/A|
|A description of the principal<br>risks facing the charity|Para 1.46|None perceived at the moment|
|Other||N/A|





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|Currently only constitution document|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|CIO|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Through existing Trustee consensus review|
|**Additional information (optional)**<br>You may choose to include further statements where relevant about:|||
|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51|Currently on an ad hoc, in-house basis|
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51|Currently establishing possible working<br>relationship with Eve Appeal and Member<br>of Cancer52.|
|Relationship with any<br>related parties|Para 1.51|See above.|
|Other||N/A|



## **Reference and Administrative details** 

|Charity name|Action on Womb Cancer|
|---|---|
|Other name the charity uses|Not applicable|
|Registered charity number|1198831|
|Charity’s principal address|PO Box 214<br>Liversedge<br>WF17 1FN|
|||





**Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Richard Hutson|N/A|05/05/2022-30/06/2023<br>(wholeyear)|N/A|
||Nicolas Orsi|N/A|05/05/2022-30/06/2023<br>(wholeyear)|N/A|
||Michele Cummings|N/A|05/05/2022-30/06/2023<br>(wholeyear)|N/A|
||Katie Allen|N/A|05/05/2022-30/06/2023<br>(wholeyear)|N/A|
||Debra Parry|N/A|05/05/2022-31/05/2023|N/A|
||Helen Shepherd|N/A|01/06/2023-30/06/2023|N/A|
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



– Corporate trustees names of the directors at the date the report was approved 

**Director name** Not applicable 

Name of trustees holding title to property belonging to the charity 

|**Trustee name**|**Dates acted if not for whole year**||
|---|---|---|
|Not applicable|||
||||
||||
||||
||||
||||





## **Funds held as custodian trustees on behalf of others** 

Description of the assets Not applicable held in this capacity Name and objects of the Not applicable charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for Not applicable safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

|**Type of adviser**|**Name**<br>**Address**|**Name**<br>**Address**|
|---|---|---|
|Not applicable|Not applicable|Not applicable|
||||
||||
||||



**Name of chief executive or names of senior staff members (Optional information)** 

Not applicable 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

Not applicable 

## **Other optional information** 

Not applicable 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s) Full name(s)** Nicolas Orsi Katie Allen **Position (eg Secretary,** Trustee Trustee **Chair, etc) Date** 17/04/2023 




**Action on Womb Cancer No (if any) 1198831 Receipts and payments accounts CC16a For the period** 5/5/2022 6/30/2023 **To from** 

|**Section A Receipts and payments**|||||
|---|---|---|---|---|
|**A1 Receipts**<br>Donation ATPS 21/09/2022<br>300<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**300**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total receipts_                       300**<br>**A3 Payments**<br>Cancer52 Membership06/06/2022<br>100<br>VistaPrint Business Cards 27/06/2022<br>17.07<br>**_Sub total_                           117**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**_Total payments_                       117**<br>**_Net of receipts/(payments)_                       183**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**-**<br>**_Cash funds this year end_                       183**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**|**to the nearest £**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**|**Last year**<br>**to the nearest £**|
||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**300**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**300**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
||||||
||**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**||
|||||**-**|
|||||**-**|
||||||
||**-**|**-**|**300**|**-**|
||||||
||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**100**<br>**17**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**117**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
||||||
||**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**||
||||||
|||||**-**|
||||||
||**-**|**-**|**117**|**-**|
||||||
||**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**|**183**<br>**-**<br>**-**<br>**183**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>Cash in charity bank account<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>K Allen<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>N Orsi|**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>12966.93<br>**-**<br>**12,967**<br>**-**<br>Agreement Error<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Nicolas Orsi<br>Katie Allen<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||N Orsi|Nicolas Orsi|4/17/2024|
||K Allen|Katie Allen|4/17/2024|



